Advancements in AI-driven diagnostics could transform cardiology, enabling autonomous interpretation of up to 80% of cardiac imaging within a decade. David Ouyang, MD, discusses overcoming barriers to running…
NEW YORK (Reuters Health) – Adding inhaled treprostinil (Tyvaso) to oral bosentan for pulmonary arterial hypertension (PAH) improves exercise capacity and quality of life, according to a report…
NEW YORK (Reuters Health) – In patients with diabetic nephropathy, high doses of B vitamins accelerate kidney dysfunction and increase the rate of myocardial infarction (MI) and strokes,…
NEW YORK (Reuters Health) – Reperfusing the myocardium within 5 hours of an infarction makes a real survival difference, research from Denmark shows. The study, conducted in patients…
NEW YORK (Reuters Health) – A study published today provides more evidence that proton pump inhibitors (PPI) interfere with clopidogrel. Recommendations from the Society for Cardiovascular Angiography and…
NEW YORK (Reuters Health) – The angiotensin II receptor blocker olmesartan medoxomil (Benicar) significantly reduces blood pressure in children with primary or secondary hypertension, according to an international…
NEW YORK (Reuters Health) – Patients with left ventricular (LV) dysfunction should receive human atrial natriuretic peptide (hANP) infusions during coronary artery bypass graft (CABG) surgery, Japanese researchers…
NEW YORK (Reuters Health) – The nonselective beta-blocker carvedilol and the beta-1-selective beta-blockers metoprolol succinate and bisoprolol have significantly different treatment effects in patients with chronic heart failure…
NEW YORK (Reuters Health) – Clopidogrel reloading does not benefit patients undergoing percutaneous coronary intervention (PCI) who are already on chronic clopidogrel therapy, Italian researchers reported online April…
NEW YORK (Reuters Health) – In older patients with normal lipids but high C-reactive protein, primary prevention therapy with rosuvastatin (Crestor) does not lower mortality, but it does…
NEW YORK (Reuters Health) – Anemia increases the risk of bleeding and death after percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), a new study shows.…
